News & Updates

Show Multimedia Only

PBP superior to pericardiocentesis in reducing malignant pericardial effusion recurrence

27 Nov 2025 by

Percutaneous balloon pericardiotomy (PBP) significantly reduces recurrence of malignant pericardial effusion (MPE) by 85 percent compared with pericardiocentesis (PC), according to the randomized controlled PMAP trial conducted by a multispecialty team of researchers from the Chinese University of Hong Kong (CUHK).

PBP superior to pericardiocentesis in reducing malignant pericardial effusion recurrence

27 Nov 2025

Polypill approach shows promise in HFrEF

27 Nov 2025 by

A once-daily polypill containing three medications (metoprolol succinate, empagliflozin, and spironolactone) is associated with improved outcomes in patients with heart failure with reduced ejection fraction (HFrEF), according to the POLY-HF trial presented at AHA 2025.

Polypill approach shows promise in HFrEF

27 Nov 2025

Osimertinib linked to cardiac events in NSCLC patients

26 Nov 2025 by

Patients with non-small cell lung cancer (NSCLC) treated with osimertinib have a higher risk of QT prolongation, reduced ejection fraction, and high-grade cardiac failure than those who received placebo or other standard therapies, reports a study.

Osimertinib linked to cardiac events in NSCLC patients

26 Nov 2025

Tirzepatide trims risk of major adverse cardiovascular events

26 Nov 2025 by

Treatment with tirzepatide 15 mg/week results in a 33-percent reduction in the risk of major adverse cardiovascular events (MACE), results of a meta-analysis have shown. Moreover, its efficacy is consistent across individuals with or without obesity.

Tirzepatide trims risk of major adverse cardiovascular events

26 Nov 2025

Elevated BP in adolescence a risk factor for atherosclerosis in middle age

25 Nov 2025

Adolescents with high BP levels are at increased risk of atherosclerosis in middle age, with the risk increasing commensurate with BP levels, according to a population-based cohort study from Sweden.

Elevated BP in adolescence a risk factor for atherosclerosis in middle age

25 Nov 2025

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

25 Nov 2025 by

The use of tirzepatide appears to reduce decline in kidney function, prevent albuminuria progression, and lower the risk of the composite kidney outcome compared with dulaglutide in patients with type 2 diabetes (T2D), atherosclerotic cardiovascular disease (ASCVD), and very high-risk chronic kidney disease (CKD), reports a study presented at Kidney Week 2025.

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

25 Nov 2025

Mediastinitis rare but fatal after paediatric cardiac surgery

24 Nov 2025

A recent study has found a low incidence of mediastinitis, a rare complication of neonatal cardiac surgery, at a tertiary referral centre, but mortality is high. Fungal infection is the main predictor of death.

Mediastinitis rare but fatal after paediatric cardiac surgery

24 Nov 2025

Is coffee proarrhythmic? New data suggest otherwise

22 Nov 2025 by

For adults treated for persistent atrial fibrillation (AF), drinking a cup of coffee every day does not trigger AF recurrence or atrial flutter and even appears to reduce its incidence, according to the DECAF trial.

Is coffee proarrhythmic? New data suggest otherwise

22 Nov 2025

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025 by

For individuals who sustained herpes zoster infection, prior receipt of recombinant zoster vaccine appears to reduce the long-term risks of major adverse cardiovascular events, dementia, and death, according to a retrospective study.

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025

Accumulated daily steps in longer bouts tied to fewer mortality, CVD events

18 Nov 2025

Daily accumulated steps in longer bouts appear to result in lower mortality and cardiovascular disease (CVD) risks than steps accumulated in shorter bouts among suboptimally active adults, reveals a study.

Accumulated daily steps in longer bouts tied to fewer mortality, CVD events

18 Nov 2025

News & Updates

Filter by Specialty:

Specialty:

PBP superior to pericardiocentesis in reducing malignant pericardial effusion recurrence

PBP superior to pericardiocentesis in reducing malignant pericardial effusion recurrence

Polypill approach shows promise in HFrEF

Polypill approach shows promise in HFrEF

Osimertinib linked to cardiac events in NSCLC patients

Osimertinib linked to cardiac events in NSCLC patients

Tirzepatide trims risk of major adverse cardiovascular events

Tirzepatide trims risk of major adverse cardiovascular events

Elevated BP in adolescence a risk factor for atherosclerosis in middle age

Elevated BP in adolescence a risk factor for atherosclerosis in middle age

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

Mediastinitis rare but fatal after paediatric cardiac surgery

Mediastinitis rare but fatal after paediatric cardiac surgery

Is coffee proarrhythmic? New data suggest otherwise

Is coffee proarrhythmic? New data suggest otherwise

Prior herpes zoster vaccination mitigates long-term complications after infection

Prior herpes zoster vaccination mitigates long-term complications after infection

Accumulated daily steps in longer bouts tied to fewer mortality, CVD events

Accumulated daily steps in longer bouts tied to fewer mortality, CVD events